GEODE CAPITAL MANAGEMENT, LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$54,572
-27.1%
20,9090.0%0.00%
Q2 2023$74,854
+89.4%
20,909
+15.3%
0.00%
Q1 2023$39,523
+18029.8%
18,1300.0%0.00%
Q4 2022$218
-99.8%
18,1300.0%0.00%
Q3 2022$117,000
+41.0%
18,1300.0%0.00%
Q2 2022$83,000
-97.0%
18,130
-94.4%
0.00%
Q1 2022$2,778,000
-20.7%
321,159
+30.9%
0.00%
Q4 2021$3,503,000
-35.5%
245,345
-0.7%
0.00%
-100.0%
Q3 2021$5,428,000
+86.4%
246,971
+13.4%
0.00%
Q2 2021$2,912,000
+1593.0%
217,708
+1183.9%
0.00%
Q1 2021$172,000
+142.3%
16,9570.0%0.00%
Q4 2020$71,000
+61.4%
16,9570.0%0.00%
Q3 2020$44,000
-25.4%
16,9570.0%0.00%
Q2 2020$59,000
+15.7%
16,9570.0%0.00%
Q1 2020$51,000
-70.7%
16,957
-50.0%
0.00%
Q4 2019$174,000
+222.2%
33,914
+100.0%
0.00%
Q3 2019$54,000
-10.0%
16,9570.0%0.00%
Q2 2019$60,00016,9570.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 315,301$1,444,0001.50%
Private Portfolio Partners LLC 54,010$247,3660.07%
Knoll Capital Management, LLC 20,000$92,0000.05%
Urban Wealth Management, LLC 2,858$13,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 100,216$459,0000.04%
XTX Topco Ltd 18,174$83,0000.03%
Rossmore Private Capital 40,661$186,0000.03%
Ergoteles LLC 224,700$1,029,0000.03%
ETF MANAGERS GROUP, LLC 87,365$393,0000.01%
Belvedere Trading LLC 40,690$343,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders